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Abstract
Cyclin-dependent kinases (CDKs) play a central role in the orderly transition from one phase of
the eukaryotic mitotic cell division cycle to the next. In this context, p27Kip1 (one of the CIP/KIP
family of CDK specific inhibitors in mammals) or its functional analogue in other eukarya prevents
a premature transition from G1 to S-phase. Recent studies have revealed that expression of a
second member of this family, p57Kip2, is induced as trophoblast stem (TS) cells differentiate into
trophoblast giant (TG) cells. p57 then inhibits CDK1 activity, an enzyme essential for initiating
mitosis, thereby triggering genome endoreduplication (multiple S-phases without an intervening
mitosis). Expression of p21Cip1, the third member of this family, is also induced in during
differentiation of TS cells into TG cells where it appears to play a role in suppressing the DNA
damage response pathway. Given the fact that p21 and p57 are unique to mammals, the question
arises as to whether one or both of these proteins are responsible for the induction and
maintenance of polyploidy during mammalian development.
The road to polyploidy
When metazoan cells proliferate, they employ the mitotic
cell cycle in which separation of sibling chromosomes
during mitosis (M-phase) and DNA synthesis during
genome duplication (S-phase) are separated by two inter-
vening gaps of time called the G1 and G2-phases to gen-
erate a repeating series of events: M→G1→S→G2→M.
Cell division (cytokinesis) occurs immediately after mito-
sis. Cell growth occurs primarily during G1-phase. In
addition, metazoan cells can exit their mitotic cell cycle
and enter a quiescent state termed G0 in which the living
state is maintained in the absence of either cell growth or
proliferation. Mitotic cell cycles restrict genome duplica-
tion to once and only once per cell division. Therefore,
G1-phase somatic cells contain two copies of their
genome (2N or diploid), whereas somatic cells in G2 or
M-phases are tetraploid (4N DNA). Cells with greater than
4N DNA content are referred to as polyploid.
Polyploidy can result from aberrant DNA re-replication
during S-phase. DNA re-replication occurs when newly
assembled replication forks re-replicate parts of the
genome that have already been replicated, resulting in
replication bubbles within replication bubbles [1]. This
occurs when one or more of the normal controls that pre-
vent reutilization of replication origins during S-phase is
circumvented. For example, DNA replication can be
induced in some metazoan cells either by over-expression
of Cdt1, a protein essential for loading the replicative
MCM DNA helicase, or by suppression of the Cdt1 spe-
cific inhibitor geminin. Both changes promote loading of
the MCM helicase at replication origins [2]. As DNA re-
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replication is not a normal part of mammalian growth
and development, it triggers programmed cell death
(apoptosis).
Polyploidy can also occur as a normal component of ani-
mal or plant development. This is common among ferns,
flowering plants, arthropods, fish, and salamanders, but it
is rare among mammals. Developmentally programmed
polyploidy is the result of multiple S-phases in the
absence of cytokinesis under conditions that prevent the
induction of apoptosis. Such cells are terminally differen-
tiated, they grow in size, but they no longer proliferate.
Thus, the simplest mechanism by which cells become
polyploid is acytokinetic mitosis, repeated S and M phases
in the absence of cytokinesis (Fig. 1). This occurs during
liver development to produce multinucleated hepatocytes
(Table 1, [3-19]). Multinucleated cells also arise by cell
fusion, a process in which G0-phase cells simply fuse their
membranes together, to produce a single cell in which
multiple nuclei are distributed throughout the cytoplasm.
This occurs during skeletal muscle development.
The remaining two mechanisms by which cells become
polyploid are genome endoreduplication and endomito-
sis. Endoreduplication occurs when a cell undergoes mul-
tiple S-phases without entering mitosis and without
undergoing cytokinesis. This results in a giant cell with a
single giant nucleus. Examples of endoreduplication are
found among protozoa, arthropods, mollusks and plants.
In contrast with these organisms, developmentally regu-
lated endoreduplication in mammals is rare. The clearest
example of endoreduplication occurs during differentia-
tion of trophoblast stem cells into the trophoblast giant
cells that are required for implantation of blastocysts into
the uterine endothelium and placental development [20].
The DNA content of these giant cells generally ranges from
8N to 64N, although levels as high as 1000N have been
reported
Endomitosis is similar to endoreduplication. Whereas
endoreduplication results from arresting cells in G2-phase
before they enter mitosis, endomitosis results from arrest-
ing cells within M-phase before they complete mitosis.
The clearest example of endomitosis occurs in the bone
marrow when megakaryoblasts differentiate into meg-
akaryocytes, the cells that give rise to blood thrombocytes
(platelets). The result is a single giant cell containing a sin-
gle multilobulated nucleus with a genome content of up
to 32N; each lobe presumably containing a diploid
genome. With time, individual lobes may separate from
one another to produce a multinucleated cell.
The pathways that regulate mitotic cell cycles are now
understood in considerable detail [21]. This allows one to
address the question, "How do mammalian cells switch
from mitotic cell cycles to mechanisms that result in ter-
minally differentiated polyploid cells?"
Preventing Polyploidy During Mitotic Cell Cycles
Mammals encode as many as ten different cyclin-depend-
ent kinases (CDKs), but only two of them are critical for
regulating mitotic cell cycles. CDK1 activity triggers the
transition from G2 to M-phase during cell proliferation,
and CDK2 activity triggers the transition from G1 to S-
phase. All eukarya contain an analogue of CDK1, the only
CDK that is essential for mammalian development. None
of the other CDKs can substitute for CDK1, and only
CDK1 can substitute for CDK2 in activating S-phase in
mitotic cell cycles [22-27].
DNA replication in mammalian cells begins with the
assembly of prereplication complexes (preRCs) at replica-
tion origins distributed throughout the genome [28].
First, a six subunit origin recognition complex (ORC)
binds to chromatin during the transition from mitotic
anaphase to G1-phase [29,30]. As cells transit from
mitotic telophase to G1-phase, the ORC:chromatin com-
plex recruits Cdc6 and then Cdt1, two proteins that are
required to load the six subunit MCM DNA helicase onto
chromatin [31]. Additional proteins are then added to
form a preinitiation complex that is acted upon by
Cdk2:cyclin E(CcnE) and by DDK (a Dbf4-dependent
protein kinase) to initiate DNA synthesis (S-phase) [32].
The MCM helicase is responsible for initiating DNA
unwinding at the replication origin, and it continues to
unwind DNA as it travels with the replication forks during
S-phase.
PreRC assembly in all eukarya occurs only in the absence
of CDK activity, and CDK activity is absent only during
the period from mitotic anaphase to late G1-phase. From
the period of late G1-phase through mitotic metaphase,
CDK activity prevents assembly of new preRCs and helps
to disassemble preRCs that formed during the anaphase
to G1-phase transition [33]. In this way, the mitotic cell
cycle prevents re-replication of the same DNA sequences
from occurring before mitosis is complete and a nuclear
membrane is present. The primary targets of CDK phos-
phorylation within the preRC are the Orc1 subunit, Cdc6
and Cdt1. Once phosphorylated these proteins are tar-
geted for degradation by the SCFSkp2 ubiquitin ligase. The
resulting polyubiquitinated proteins are then degraded by
the 26S proteasome. In addition, unphosphorylated Cdt1
is a substrate for the CDRDdb1 ubiquitin ligase. Both the
SCF and CDR ubiquitin ligases are active only during S
and G2-phases. As if this were not sufficient, multicellular
eukarya contain one more mechanism for preventing
loading of the MCM helicase. Cdt1 is specifically inhib-
ited by binding to geminin, a unique metazoan protein
expressed only during S, G2 and early M-phases. Conse-Cell Division 2009, 4:10 http://www.celldiv.com/content/4/1/10
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Developmentally regulated polyploidy Figure 1
Developmentally regulated polyploidy. Normal mitotic cell cycles results in two diploid mononucleated daughter cells 
with each nucleus containing two copies of each homologous chromatid (2N). Re-replication of DNA during S-phase is an 
aberrant event that produces giant nuclei and apoptosis. However, developmental signals can induce cells to become polyploid 
either by completing mitosis in the absence of cytokinesis [(C-), acytokinetic mitosis], or by melding two G0-phase cells into a 
single cell containing two G-phase nuclei (cell fusion), or by arresting cells in G2-phase and then inducing another S-phase 
(endoreduplication), or by arresting cells in M-phase (M*) in the absence of cytokinesis (endomitosis). Multiple rounds of acy-
tokinetic mitosis produce multinucleated giant cells. Multiple cell fusion events produce multinucleated myotubes in skeletal 
muscle. Multiple rounds of endoreduplication (endocycles) produce mononucleated giant cells, whereas multiple rounds of 
endomitosis produce a single multilobular nucleus.Cell Division 2009, 4:10 http://www.celldiv.com/content/4/1/10
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quently, both geminin and Cdk2:cylin A(CcnA) activity
are required to prevent DNA re-replication in mammalian
cells [34].
Suppression of CDK activity and activation of preRC
assembly begins when the anaphase promoting complex
(APC), a ubiquitin ligase, targets the mitotic cyclin A
(CcnA) and cyclin B (CcnB) for ubiquitin-dependent pro-
teolysis by the 26S proteasome (Fig. 2) [35]. This event
cannot occur until several APC subunits, including its sub-
strate targeting subunit Cdc20, have been phosphorylated
by Cdk1:CcnA or Cdk1:CcnB. Even then, APCCdc20 is held
back by the spindle checkpoint until metaphase is com-
plete. Once the APC becomes active, not only are the
mitotic cyclins degraded, thereby suppressing CDK1 activ-
ity and allowing the homologous chromatids to separate
(anaphase), but geminin is also degraded, thereby allow-
ing preRC assembly to begin.
Once the mitotic cyclins are degraded, CDK1 protein is
converted into an inactive form through site-specific
phosphorylation by the Wee1 and Myt1 protein kinases.
To insure that conditions in G1-phase remain suitable for
preRC assembly, two additional events occur during the
M to G1-phase transition. As Cdk1 activity disappears, the
APCCdc20 is dephosphorylated and therefore inactivated.
In its place, the APC core subunits recruit a second sub-
strate targeting protein called Cdh1. APCCdh1 has the same
substrate specificities as APCCdc20, except that APCCdh1
functions only in the absence of CDK activity, whereas
Table 1: Polyploidy and expression of p57 and p21 in mice
Tissue p57 p21 Polyploid Mechanism
Placenta [18] + + + Endoreduplication
trophoblast stem cell→giant cell
Bone Marrow [4] - + + Endomitosis
megakaryoblast→megakaryocyte
Liver [3] + + + Acytokinetic Mitosis
hepatocyte development
Skeletal Muscle [13] + + + Cell Fusion
myoblast→myotube
Bone [15] ? + + Cell Fusion
monocytes→osteoclasts
Placenta [8,14] ? + + Cell Fusion
Syncytiotrophoblasts
Heart Muscle [5,6,19] + + +* ?
cardiomyocytes→myotube
Skin [9] + + +* ?
basal epithelial cell→keratinocyte
Kidney [10] + - +* ?
primitive podocyte→mature podo
Eye [7,11] + ? ?
lens epithelial cell→fiber cell
Bone [12] + + ?
osteoblast→bone
Cartilage [16,17] + ? ?
Chondrocytes→fiber cell
→ Indicates expression of p57 and p21 up-regulated during normal cell differentiation.
* Polyploidy results from injury (e.g. heart attack) or infection.Cell Division 2009, 4:10 http://www.celldiv.com/content/4/1/10
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APCCdc20 functions only in the presence of CDK activity.
Therefore, expression of the mitotic cyclins and geminin
continues to be suppressed.
p27Kip1 Prevents Premature Entrance Into S-Phase During 
Mitotic Cell Cycles
The second event is the appearance of the CDK-specific
inhibitor p27 (Fig. 2). All mammals encode three proteins
(p21Cip1, p27Kip1 and p57Kip2) that belong to the CIP/KIP
family and specifically inhibit cyclin-dependent protein
kinases, primarily CDK1 and CDK2. One member of this
CIP/KIP family, p27 [or its analogue in budding yeast
(Sic1), fission yeast (Rum1), flies (Dacapo), and frogs
(Xic1)], delays the transition from G1 to S-phase until
assembly of prereplication complexes (preRCs) at replica-
tion origins is complete. It does so by inhibiting
CDK2:CcnE activity. When cells exit mitosis, cyclin E
begins to appear. Since cyclin E is not a substrate for
APCCdh1, it can activate CDK2. Therefore, the primary role
of p27 is to delay the accumulation of Cdk2:CcnE activity
until preRC assembly is complete. With time, phosphor-
ylation of p27 by Cdk2:CcnE converts p27 into a substrate
for SCFSkp2 and subsequent proteolysis, thus releasing
cells into S-phase. Premature activation of CDK activity
results in premature entrance into S-phase with the conse-
quence that too few replication origins are activated
[36,37]. This means that replication must travel longer
distances, thereby increasing the probability of replication
fork malfunction and genomic instability.
p57Kip2 Triggers Endoreduplication in Trophoblast Stem 
Cells
Endocycles can occur only when mitosis and cytokinesis
are prevented under conditions that permit assembly and
subsequent activation of preRCs. Therefore, the transition
from a mitotic cell cycle to an endocycle in mammals
The role of p27Kip1 in preventing premature activation of S-phase Figure 2
The role of p27Kip1 in preventing premature activation of S-phase. Cdk1:CcnA and Cdk1:CcnB activities are both 
required to induce mitosis during mammalian cell proliferation. Either activity is required to activate the APCCdc20 ubiquitin 
ligase which, in turn, targets the mitotic cyclins A and B for ubiquitin mediated degradation by the 26S proteasome. Cdk1:CcnA 
also phosphorylates the Orc1 subunit and thereby prevents ORC binding to chromatin until metaphase is completed and 
APCCdc20 inhibits Cdk1 activity by reducing the pools of mitotic cyclins A and B. Once this occurs, and the spindle checkpoint 
releases APCCdc20, cells move into anaphase and APCCdc20 targets geminin for degradation. In the absence of CDK activity, 
Orc1 and Cdc6 are dephosphorylated and bind to chromatin. In the absence of geminin, Cdt1 loads the MCM DNA helicase 
onto ORC•Cdc6•chromatin sites. Cdk1 protein is inactivated by the Wee1 and Myt1 protein kinases. APCCdh1 appears and tar-
gets Cdc20 for ubiquitin-dependent degradation. The cells are now maintained in G1-phase by APCCdh1 preventing the synthe-
sis of cyclins A and B. However, cyclin E is not an APC substrate. As cyclin E appears, Cdk2:CcnE activity activates the 
replication complexes and drives the cells into S-phase. The role of p27 is to prevent premature accumulation of Cdk2:CcnE 
activity.Cell Division 2009, 4:10 http://www.celldiv.com/content/4/1/10
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requires suppression of CDK activity with concomitant
inactivation of geminin. Once preRC assembly is com-
plete, then CDK activity must be restored in order to initi-
ate S-phase. This series of events is then repeated several
times without going through mitosis, resulting in cells
with a single nucleus that contains integral multiples of
2N DNA content (Fig. 3).
Recent analysis of the differentiation of mouse trophob-
last stem (TS) cells into trophoblast giant (TG) cells has
revealed that endoreduplication is triggered by suppres-
sion of CDK1 activity by the CDK specific inhibitor p57
[18]. Cultured TS cells undergo normal mitotic cell cycles
in the presence of fibroblast growth factor 4 (FGF4), and
differentiate into TG cells when deprived of FGF4, condi-
tions that mimic trophectoderm development in vivo
[38]. Differentiation of TS cells into TG cells is accompa-
nied by genome endoreduplication with concomitant
expression of both p21 and p57; cellular levels of p27
remain unchanged [18]. Of p21 and p57, only the latter is
required to trigger endoreduplication and to sustain the
subsequent endocycles. p57 is expressed at the end of S-
phase and localized to the nucleus where it inhibits CDK1
activity and prevents entrance into mitosis (Fig. 4A). Con-
sequently, cells accumulate in G2-phase. In the case of TS
cells, they begin a new round of genome duplication for
which both p57 and APCCdh1 are essential [18,39]. Recent
analysis of endocycles in Drosophila follicle cells demon-
strates that geminin activity during endocycles is regulated
by APCCdh1/Fzr activity [40,41]. Thus, the role of p57 is to
inhibit CDK1, one consequence of which is the appear-
ance of APCCdh1 in place of APCCdc20. The role of APCCdh1
is to inactivate geminin. The essential role of p57 in trig-
gering endoreduplication in TS cells is the single feature
that distinguishes endocycles in mammalian cells from
endocycles in Drosophila [1].
Several lines of evidence confirm that the role of p57 dur-
ing differentiation of TS cells into TG cells is to inhibit
CDK1 activity [18]. The appearance of p57 was coincident
with the disappearance of CDK1 activity and the appear-
ance of endoreduplication. CDK1 co-immuno-precipi-
tated with p57 from lysates of TG cells, but not TS cells. TS
cells that lack a functional p57 gene fail to arrest mitosis
and fail to endoreduplicate their genome when deprived
of FGF4, although they do increase their size and express
genes characteristic of TG cells. p57-/- TS cells deprived of
FGF4 form multinucleated giant cells as a consequence of
incomplete cytokinesis (Fig. 4). p57-/- TS cells cannot
endoreduplicate their genomes, because p57 is required
to inhibit CDK1. This was confirmed by the fact that
RO3306, a drug that selectively inhibits CDK1 [18,42],
induces endocycles in p57-/- TS cells as effectively as it
does in wild-type TS cells cultured in the presence of
FGF4. This observation provides an explanation for the
appearance of multinucleated syncytiotrophoblasts [8].
Like p57-/- TG cells, syncytiotrophoblasts express p21, but
not p57 [14], suggesting that loss of p57 activity in these
trophoblast cells results in acytokinetic mitosis. Alterna-
tively, syncytiotrophoblasts may result from cell fusion
[8].
The fact that p27 is expressed at the same level in both TS
and TG cells, and that p21 is also induced during differen-
tiation of p57-/- TS cells into TG cells suggests that neither
of these CDK-specific inhibitors triggers endoreduplica-
tion in response to FGF4 deprivation. In fact, endoredu-
plication in p21-/- TG cells is delayed until the appearance
of p57. One explanation for the failure of either p21 or
p27 to substitute for the role of p57 in TS cell differentia-
tion is that neither p21 nor p27 are expressed at the same
time and place as p57. However, a recent study in which
the p57 gene was replaced by the p27 gene in mice sug-
gests that this is not the case. p27 shares sequence similar-
ity with both the N-terminal and C-terminal regions of
p57. Mice containing both the normal p27 alleles as well
as two additional copies of the p27 gene under control of
the native p57 gene promoter revealed that many, but not
all, of the defects in mouse development associated with
the absence of a functional p57 gene could be rescued by
p27 [43]. One tissue that did not respond to p27 therapy
was the placenta. Recombinant p27 protein expressed
from the p57 promoter failed to accumulate in the pla-
centa, although the level of p27 mRNA was equivalent to
that of p57 mRNA in wild-type placenta. Thus, p27
expressed from the p57 promoter is selectively degraded
whereas p57 expressed from the p57 promoter is not.
Moreover, KPC and Pirh2, two ubiquitin ligases that selec-
tively target p27 for degradation [44,45], are expressed
prominently in the same placental layers that express high
levels of p57. Therefore, p27 can not compensate for p57
in specific regions of the placenta, which is why placental
dysplasia observed in p57 null mice is not restored by
replacing p57 with p27.
p57Kip2 Oscillations Sustain Endocycles
The requirement for p57 to trigger endoreduplication in
TS cells by inhibiting CDK1 presents a conundrum,
because p57 is also a potent inhibitor of CDK2, an
enzyme that normally drives cells from G1-phase into S-
phase. Just as in mitotic cell cycles, activation of S-phase
requires either Cdk2 or Cdk1 activity [18]. Therefore, the
cellular levels of CDK specific inhibitors must oscillate
during endocycles just as they do doing mitotic cell cycles.
In fact, p57 is present in TG cells only when they are not
undergoing DNA replication (G-phase [18,46]). Inactiva-
tion of both p27 and p57 is achieved by site-specific phos-
phorylation of these two proteins by Cdk2:CcnE, one of
the two protein kinases that activates preinitiation com-
plexes to begin DNA synthesis. Cyclin E (CcnE) isCell Division 2009, 4:10 http://www.celldiv.com/content/4/1/10
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Fluorescence activated cell sorting (FACS) analysis of mouse trophoblast stem (TS) cells undergoing mitotic cell cycles or  endoreduplication as they differentiate into trophoblast giant (TG) cells when deprived of FGF4 Figure 3
Fluorescence activated cell sorting (FACS) analysis of mouse trophoblast stem (TS) cells undergoing mitotic 
cell cycles or endoreduplication as they differentiate into trophoblast giant (TG) cells when deprived of FGF4. 
p57-/- TS cells respond to the same conditions by forming multinucleated TG cells. Data are from [18].Cell Division 2009, 4:10 http://www.celldiv.com/content/4/1/10
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Figure 4 (see legend on next page)Cell Division 2009, 4:10 http://www.celldiv.com/content/4/1/10
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required to sustain endocycles in mammals [47,48], and
unlike the mitotic cyclins A and B, cyclin E is not an APC
substrate [35]. The phosphorylated forms of p27 and p57
are substrates for the ubiquitin ligase SCFSkp2 which tar-
gets them for proteolysis by the 26S proteasome [49,50].
This step is necessary for both mitotic cell cycles and for
endocycles. If a non-degradable form of p57 that lacks the
CDK-target site is expressed in Rcho-1 cells (a rat cell line
that models TS cells), or if wild-type p57 is over-expressed
in these cells, these cells neither proliferate nor endoredu-
plicate their genome [46]. The events occur after removal
of FGF4 that trigger accumulation of p57 as the TS cells
differentiate into TG cells remain to be determined.
Endocycles are successive oscillations of G and S-phases
(Fig. 4B). In both flies and mammals, these oscillations
require both CDK2:cyclin E and APCCdh1/Fzr activities [1].
Since phosphorylation of Cdh1/Fzr by CDK2:cyclin E
inhibits APCCdh1/Fzr activity [51], oscillations of APCCdh1/
Fzr activity appear to be driven by periodic inactivation of
Cdh1/Fzr by CDK2:cyclin E [40,41]. Low CDK2:cyclin E
activity during G-phases allows high APCCdh1/Fzr activity,
which in turn, degrades mitotic cyclins and Geminin,
thereby initiating preRC assembly. High CDK2:cyclin E
activity during the G1 to S-phase transition inhibits
APCCdh1/Fzr, thereby initiating S-phase and allowing gem-
inin to accumulate [41]. Geminin should prevent DNA re-
replication during endocycle S-phases. CDK2:cyclin E also
phosphorylates Cdc6, thereby restricting preRC assembly
to the G-phase while simultaneously protecting Cdc6
from APC-dependent proteolysis [52]. Cdc6 is subse-
quently dephosphorylated and assembled into preRCs
during the G-phase. Thus, inactivation of CDK1 results in
premature expression of APCCdh1/Fzr activity which rein-
forces inhibition of CDK1 activity by degrading mitotic
cyclins, and in addition, eliminates the block to preRC
assembly imposed by geminin.
The role of p57 during endocycles, and presumably p27 as
well, is to prevent CDK1:Cyclin E or CDK2:Cyclin E activ-
ities from accumulating before preRC assembly is com-
plete. Otherwise, cells would initiate S-phase prematurely,
resulting in genomic instability that would trigger apopto-
sis. The reiteration of these events, driven by the oscilla-
tion of CDK2:Cyclin E activity, appears to be the primary
driving force behind multiple endocycles [40,41]. In
mammalian mitotic cell cycles, CDK2:Cyclin A phospho-
rylates cyclin E, thereby enabling SCFSkp2 to target cyclin E
for ubiquitin-dependent degradation. Presumably, the
same mechanism accounts for oscillation of CDK2:Cyclin
E activity during mammalian endocycles, as well.
A Role For p21Cip1 In Production Of Polyploid Cells
One remarkable feature of cells undergoing endocycles is
their ability to tolerate genotoxic stress induced either
from DNA damage or incomplete DNA replication. In
Drosophila, this apparently is due to the absence of a
checkpoint that insures completion of S-phase [53-55]. In
mammals, suppression of apoptosis in endocycling cells
is linked to expression of the CDK-specific inhibitor p21
[18], a cyclin-dependent protein kinase inhibitor whose
abundance increases in cells exposed to radiation or other
DNA-damaging agents. Consequently, CDK-dependent
cell cycle events are arrested until these problems can be
corrected. Mice that lack p21 are hypersensitive to
gamma-irradiation and exhibit a greater incidence of met-
astatic tumors [56]. The primary role of p21 during TS to
TG cell differentiation appears to be prevention of apop-
tosis in response to incomplete DNA synthesis and DNA
damage that may occur during endoreduplication. It does
this by suppressing (either directly or indirectly) expres-
sion of Chk1, a key intermediary in the ATR-Chk1-Cdc25
DNA damage response pathway (Fig. 5). Chk1 is required
for preventing proliferating cells from entering mitosis
with DNA damage or stalled replication forks [57,58]. A
strong correlation exists between expression of p21, sup-
The role of p57Kip2 in the initiation and maintenance of endocycles Figure 4 (see previous page)
The role of p57Kip2 in the initiation and maintenance of endocycles. (A) Endocycles are initiated in mouse TS cells in 
the absence of FGF4. When p57 is expressed in TS cells as a consequence of FGF4 deprivation, Cdk1 activity is inhibited. Con-
sequently, APCCdh1 will be assembled instead of APCCdc20. Orc1 will not be phosphorylated. In the absence of phosphorylation, 
any Orc1-P and Cdc6-P produced during S and G2-phases by Cdk2:CcnA will be dephosphorylated by cellular protein phos-
phatases. In the absence of CDK activity, APCCdh1 is assembled and targets geminin for degradation. Thus, the cell has effec-
tively entered a G1-phase-like state without passing through mitosis. (B) Based on studies of endocycles in Drosophila follicle 
cells, Cdk2:cyclin E activity oscillates such that it is high during the S-phases and low during the G-phases. In contrast, APCCdh1/
Fzr activity is high during G-phases and low during S-phases [40,41]. This is in keeping with the fact that Cyclin E:Cdk2 inacti-
vates Cdh1/Fzr [51] suggesting that APCCdh1/Fzr oscillations are driven by periodic inhibition of Fzr by Cyclin E:Cdk2 [40,41]. 
Similarly, geminin levels are high during S-phase and low during gap phase [41]. In cells programmed for endoreduplication, inhi-
bition of Cdk1 activity results in premature assembly of APCCdh1/Fzr. Thus, a feedback loop exists that reinforces inhibition of 
Cdk1 activity triggered by endocycle entry. In the absence of Geminin and CDK-dependent protein phosphorylation, preRC 
assembly occurs as though cells had entered G1-phase. Symbols: ⊥ indicates target is inhibited, +→ indicates target is activated, 
→ indicates product of reaction.Cell Division 2009, 4:10 http://www.celldiv.com/content/4/1/10
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pression of Chk1, and reduced sensitivity to genotoxic
stress [18]. Cells that express Chk1, such as TS and ES
cells, are sensitive to genotoxic stress, whereas cells that do
not express Chk1 (e.g. TG cells) are not. p21 alone can
down-regulate Chk1 protein levels in cancer cells, and
cancer cells lacking p21 do not suppress Chk1 in response
to genotoxic stress [59]. However, TG cells lacking p21
still suppress Chk1 protein levels, but only after they
express p57 [18]. Presumably, p57 can substitute for p21
in suppressing Chk1 protein synthesis.
p21Cip1 And p57Kip2 Promote Cell Fusion In Myoblasts
Three examples of developmentally regulated cell fusion
have been reported (Table 1). One occurs in bone marrow
where monocytic macrophages differentiate into polynu-
cleated osteoclasts, the cell responsible for bone resorp-
tion by removing its mineralized matrix. Another is
syncytiotrophoblasts, multinucleated cells found in the
placenta. They are the outer syncytial layer of the trophob-
lasts and actively invade the uterine wall. A well character-
ized example, however, is the differentiation of skeletal
muscle myoblasts into myotubes. During myogenesis, for
example, mononucleated myoblasts withdraw from the
cell cycle, initiate muscle specific gene expression, and
subsequently fuse with one another to form multinucle-
ated myofibers [60]. Cell cycle arrest is an essential step in
skeletal muscle differentiation. Once arrested, mononu-
cleated myoblasts fuse to form syncytial myofibers. p21
and p57 are highly expressed in skeletal muscles and
redundantly induce cell cycle arrest during differentiation.
Role of p21Cip1 in preventing apoptosis during endocycles Figure 5
Role of p21Cip1 in preventing apoptosis during endocycles. Upon completion of DNA replication in mitotic cell cycles, 
Cdc25 protein phosphatase and cyclin B are transported into the nucleus where they convert the inactive form of Cdk1 into 
an active form that can bind to cyclins and initiate mitosis. ATR is a protein kinase that senses the presence of excess single-
stranded DNA resulting either from stalled replication forks, or from DNA damage. ATR then phosphorylates Chk1. This acti-
vates the Chk1 protein kinase and it, in turn, phosphorylates Cdc25, inhibiting it and thereby preventing cells from entering 
mitosis until the problem is corrected. p21 either directly or indirectly prevents expression of Chk1 protein. Under these con-
ditions, cells do not trigger apoptosis in response to incomplete DNA synthesis or DNA damage.Cell Division 2009, 4:10 http://www.celldiv.com/content/4/1/10
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Inactivation of either p21 or p57 does not affect muscle
differentiation in mice. However, inactivation of both
genes produced the same muscle deficient phenotype
observed with nullizygous myogenin mice [56]. Their
activity is linked directly to MyoD expression, one of the
earliest myogenic regulatory proteins expressed during
muscle differentiation. MyoD commits mesoderm cells to
a skeletal lineage, and in doing so it can block cell prolif-
eration. MyoD is phosphorylated on Ser 200 in proliferat-
ing myoblasts by either Cdk1 or Cdk2 in myoblasts
[58,59]. During differentiation MyoD induces expression
p21 and p57 [61]. p21 and p57 prevent CDK-dependent
phosphorylation of MyoD and thereby prevent its ubiqui-
tin-dependent degradation. Analysis of synchronized
myoblasts reveals that they exit the mitotic cell cycle dur-
ing G1-phase, when MyoD levels are highest. Thus, inhi-
bition of CDK:cyclin E activity by either p21 or p57 is
likely the mechanism by which these CDK specific inhib-
itors trigger differentiation of myoblasts into myotubes.
Possible Role For CIP/KIP Proteins In Endomitosis
Another role for p21 may be in triggering endomitosis
during differentiation of megakaryoblasts (MKBs) into
megakaryocytes (MKCs). Thrombopoietin stimulates dif-
ferentiation of MKBs into MKCs with concomitant stimu-
lation of p21 expression [62]. As with TS to TG cell
differentiation, Cdk1 is degraded during MKB to MKC dif-
ferentiation, p21, p27 and cyclin E levels remain high, and
cyclins A and B are present, but at a reduced level
[4,63,64]. However, in contrast with TG cells, MKCs
express only p21 and p27; p57 has not been detected [4],
suggesting that p21 may inhibit entrance into mitosis.
Given the role proposed for p21 during normal mitotic
cell cycles, stimulation of p21 in cells developmentally
programmed for endoreduplication could have the same
effect as stimulation of p57 that is to arrest mitosis.
During mitotic cell cycles, p21 accumulates transiently in
late G1-phase of where it helps to prevent premature entry
into S-phase by inhibiting CDK2:cyclin E activity [65],
and it is then targeted for degradation by the SCF ubiqui-
tin ligase during the G1 to S-phase transition. p21 again
accumulates during G2-phase where it helps to prevent
premature activation of CDK1-mitotic cyclin activities,
and it is then degraded in prometaphase following its
ubiquitination by APCCdc20 [66]. Thus, stimulation of p21
levels during G2-phase would provide cells with another
mechanism to inhibit Cdk1 activity, arrest mitosis and
initiate preRC assembly. However, mice nullizygous for
p21 are viable and fertile [67] and produce MKCs [4] that
contain giant nuclei indistinguishable from those in wild-
type animals. Since p57 expression is not induced in these
p21-/- MKCs, p27 may substitute for the role of p21 dur-
ing MKB to MKC differentiation, as it appears to do so in
osteoblast differentiation [68]. As discussed below,
genetic analyses of mouse development and cell differen-
tiation in vitro has revealed functional redundancies
among the CIP/KIP family of proteins.
MKB differentiation is reminiscent of differentiation of
p57-/- TS cells into TG cells. TS cells expressing both p57
and p21 arrest proliferation in G2-phase and endoredu-
plicate. However, TS cells that are nullizygous for p57 con-
tinue to divide in the absence of FGF4 until p21 is
expressed, at which time they become multinucleated
[18]. These results reveal that Cdk1 activity is strongly
inhibited when p57 and p21 are both expressed during TS
to TG cells differentiation, but only weakly inhibited
when p21 alone is expressed. Therefore, when throm-
bopoietin stimulates p21 expression in MKBs, cells will
not arrest in G2-phase (as they do when p57 is expressed),
but will progress into mitosis albeit slowly. Complete
inhibition of CDK1 in these cells may require additional
steps.
Other mechanisms that have been suggested for induction
of endomitosis in MKBs include suppression of cyclin B1
expression [69,70], suppression of CDC25C expression
[71] [the protein phosphatase that converts Cdk1-P into
its active form (Fig. 5)], and degradation of CDK1 [72].
One difficulty in these studies is that many of them have
used either megakaryocytic leukemia cell lines, such as
UT-7 and HEK, or immortalized cell lines, such as MegT,
which may not accurately represent the events in differen-
tiation of primary MKBs [62,69,72]. Obviously, further
studies will be required to elucidate the mechanism of
endomitosis and its relationship with endoreduplication.
Whatever the mechanism, it must account for the fact that
MKCs enter mitosis but do not complete it. Therefore,
some CDK1:mitotic cyclin activity is needed to transit
prophase, prometaphase and metaphase and the presence
of this activity will be needed in successive cycles. In addi-
tion, the transition from metaphase to anaphase requires
the appearance of APC activity with concomitant the loss
of CDK1:mitotic cyclin activity.
Acytokinetic Mitosis
Acytokinetic mitosis occurs when cells separate their
homologous chromosomes into two groups (mitosis) but
fail to form a cleavage furrow in the center of the cell and
undergo cell division (cytokinesis). This occurs during
postnatal liver development. Liver parenchyma undergoes
dramatic changes characterized by gradual appearance of
tetraploid and octoploid hepatocytes containing one or
two nuclei [73]. Thus, hepatocytes are exclusively diploid
in the liver of a newborn rat, but in adult rats, approxi-
mately 25% of these cells are diploid, 70% are tetraploid
and 5% are octoploid. Binucleated tetraploid hepatocytes
are the result of acytokinetic mitosis. The mechanism that
specifically prevents cytokinesis is unknown.Cell Division 2009, 4:10 http://www.celldiv.com/content/4/1/10
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TG cells in bovine and alpaca placenta can also develop
two or more nuclei, indicative of cycles of acytokinetic
mitoses or, in the case of alpaca placenta, lobulated nuclei
suggestive of endomitosis [74]. These multinuclear TG
cells are reminiscent of the multinuclear p57-/- TG cells
that develop in vitro [18], suggesting that down-regula-
tion of p57 during placental development could give rise
to acytokinetic mitosis.
Cell Differentiation
Induction of p57 appears to play a critical role in differen-
tiation of some cell types by arresting their mitotic cell
cycle without inducing polyploidy. Osteoblasts, for exam-
ple, differentiate into mineralized bones. In doing so, they
appear to first arrest proliferation by induction of p57, an
event that can be induced in vitro by serum starvation of
osteoblastic cells [12]. Events that increase p57 levels in
osteoblasts stimulate differentiation into bone, whereas
events that decrease p57 levels inhibit differentiation.
A second example is chrondrocyte differentiation, an
event required for bone formation. Chondrocytes pass
from a proliferative state to a postmitotic, hypertrophic
state equivalent to G0-phase. As with osteoblasts and
myoblasts, growth arrest is a central feature of chrondro-
cyte differentiation. Mice lacking p57 exhibit chondrodys-
plasia and loss of collagen type X expression. Over-
expression either of p57, or of p57 and p21 together
induced growth arrest in chondrocytes, but it was not suf-
ficient for the induction of collagen type X [17]. Thus,
p57-mediated growth arrest is not sufficient for expres-
sion of the hypertrophic phenotype, but rather it occurs in
parallel with other aspects of the differentiation pathway.
Conversely, parathyroid hormone-related peptide stimu-
lates chondrocyte proliferation during bone develop-
ment, and the effects of this mitogen are mediated, at least
in part, through suppression of p57 expression [16].
Other examples are skeletal myoblasts, lens fiber cells, ret-
inal cells, keratinocytes and intestinal epithelial cells
(Table 1).
The Special Place Of p57 In Mammalian Development
p57 is the only CIP/KIP protein that is essential for mam-
malian development. Compared to p21 and p27, p57
exhibits a restricted pattern of expression during embry-
onic development and in adult tissues. However, its
expression does not always result in polyploid cells indi-
cating that expression of p57 only in the proper context of
development can result in polyploid cells. Expression of
p57, on the other hand, is often associated with terminal
differentiation (Table 1). In the mouse, p57 and p21 are
co-expressed in cartilage and skeletal muscle during devel-
opment although other tissue types (brain, skin, nose,
and eyes) exhibit non-overlapping patterns of p21 and
p57 [75,76]. Like p57 and p21, p27 is also expressed
highly in the skeletal muscle and other tissues expressing
p27 include the brain, heart, placenta, lung, kidney, and
pancreas [77]. Expression of p57 appears to be restricted
to terminally differentiated cells such as trophoblast giant
cells, myotubes, retinal fiber cells, osteoblasts, and kerati-
nocytes. Highest expression of p57 is observed in the pla-
centa.
In mouse embryos, p57 protein is first detected in the
heart (E10.5), and then in neural tissues (E11.5) called
Rathke's pouch and the infundibulum, which become the
pituitary, and some cells of the dorsal brain [19]. By day
E13.5, p57 is present in cells of the heart and skeleton-
muscular system, neural system (including choroid
plexus), parenchymal organs such as lung and kidney,
and in extraembryonic tissues of the placenta. After E13.5,
p57 protein levels decline markedly in all tissues except
skeletal muscle where staining persists at relatively high
levels to day E17.5. In adult mice, p57 RNA is localized to
the brain, eye, cartilage, skeletal muscle, kidney, heart,
lung, and liver [75].
Functional Redundancy Of CIP/KIP Proteins
CIP/KIP family members exhibit a remarkable ability to
substitute for one another in various functions. For exam-
ple, mice lacking p21 develop normally [67], presumably
because the roles of p21 can be carried out either by p27
or p57. Nevertheless, p21 heterozygous and nullizygous
mice are more sensitive to gamma-irradiation [56], con-
sistent with the role of p21 in arresting cell proliferation
during periods of genotoxic stress. Mice lacking p27 sur-
vive into adulthood, although they exhibit abnormalities
that include organ hyperplasia, female sterility, and sus-
ceptibility to tumorigenesis [78]. Mice lacking maternal
p57 die before birth or very shortly thereafter [79-81].
Thus p57 is the only family member of this group that is
required for embryonic development. p57 null mice have
large placenta (placentomegaly). Additionally these mice
show lens cell hyperproliferation and apoptosis, abdomi-
nal muscle defects and cleft palate. These phenotypes cor-
relate well with the restricted expression pattern of p57
(Table 1).
Defects in the placenta associated with the lack of p57
function are explained by the inability of the cells to ter-
minally differentiate into TG cells. In the absence of CDK
inhibitor p57, the cells continue to go through mitosis
resulting in large placenta. This was also observed when
TS cells derived from p57 null blastocysts were differenti-
ated into TG cells [18]. Unlike the wild type TG cells p57
null cells continued to proliferate and did not enter a ter-
minally differentiated state. In contrast with the essential
role of p57 in the formation of TG cells, the role of p21 is
not essential, apparently because p57 substitute for p21Cell Division 2009, 4:10 http://www.celldiv.com/content/4/1/10
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during differentiation of p21-/- TS cells into TG cells [18].
p57 is also involved in the terminal differentiation of ocu-
lar lens cells into secondary lens fiber cells. As with TG
cells, loss of p57 also resulted in additional cell divisions
in the lens [81].
Interestingly, both the lens cells and cells in the placenta
underwent additional cell division in the p27/p57 double
knockout animals [82]. This suggests that p27 partially
compensates for the role of p57 in the placenta and lens
cells. However, whether this compensatory role of p27
applies to TG cells or not is not clear. While p21, p27 and
p57 are all expressed in TG cells, only p57 appears to
inhibit CDK1 activity in TG cells and is required for
endoreduplication. p57 null TG cells express high levels
of both p21 and p27, but continue to proliferate. Thus the
role of p57 in TG cells can neither be compensated by p21
nor p27. In other tissues, however, the different family
members seem to compensate for each other very well.
For example both p21 and p57 are expressed at higher lev-
els in skeletal muscles, but neither single mutant animal
showed significant defects in muscle differentiation.
However, animals that lacked both p21 and p57 showed
profound defects in muscle development [83]. Absence of
both p21 and p57 resulted in over-proliferation of the
muscle cells.
Conclusion
p57 Is Often, But Not Always, Associated With Polyploidy
Of the three CIP/KIP CDK inhibitors in mammals, only
p27 and p21 have been shown to play a role in regulating
mitotic cell cycles. p27 is expressed in all mammalian cells
where it is primarily responsible for preventing premature
entrance into S-phase, a role that may be common to both
mitotic cells cycles and endocycles. p21 facilitates this role
and in addition helps to prevent premature entrance into
M-phase. The up-regulation of p21 in response to DNA
damage arrests cells in G1-phase, revealing that excessive
levels of CIP/KIP proteins can block DNA replication.
Although more research is needed to clearly define the
role of p21 in the differentiation and maintenance of
polyploid cells, it appears to be involved in preventing
polyploid cells from undergoing apoptosis through sup-
pression of checkpoint pathways.
p57 is expressed at high levels specifically in terminally
differentiated cells, most of which are clearly polyploid. In
fact, p57 has been shown to be expressed in six of the
eight tissues known to produce polyploid cells (Table 1).
Surprisingly, however, the ability of p57 to induce endo-
cycles during terminal differentiation of a mammalian tis-
sue appears to be unique to the trophoblast cell lineage.
Endoreduplication occurs only when p57 is expressed in
TS cells. It is not expressed during endomitosis in MKCs,
and its role in myoblast cell fusion is to arrest cells in G0-
phase. The role of p57 in the other six tissues where it is
expressed is unknown, but its likely role is to arrest cells
either in G0 or G2-phase.
Going Polyploid
The results described above and summarized in Table 1
suggest a unifying view of developmentally programmed
polyploidy. First, the essential step is inhibition of cytoki-
nesis, not mitosis. Once cells lose the ability to divide, the
presence or absence of p57 and/or p21 determine which
of three possible roads to polyploidy is taken. Increasing
the level of CIP/KIP proteins above those that occur dur-
ing mitotic cell cycles arrests cells either in G0 (e.g. myob-
lasts), or in G2 (e.g. TS cells) or in anaphase (e.g. MKBs).
When cells are arrested either in G2 or anaphase, preRC
assembly occurs, because CDK activity is suppressed and
geminin is degraded. These cells will undergo multiple S-
phases without an intervening mitosis and therefore pro-
duce a single nucleus. However, if the cellular level of CIP/
KIP inhibitors is not significantly elevated in cells that
cannot undergo cytokinesis, then acytokinetic mitosis
occurs to produce multinuclear cells. The advantage of
either acytokinetic mitosis or cell fusion over endoredu-
plication and endomitosis may simply be that the former
do not require uncoupling of checkpoint controls from
genome duplication, whereas the later do.
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